Q&A With James List From Janssen Pharmaceuticals: Development Pipeline Gives Hopes to Future Kidney Disease Treatment Options

%jwplayer%

With two medications moving through the pipeline, patients with diabetic kidney disease may soon get a new treatment to prevent their developing end stage kidney disease.

James List, MD, PhD, Global Therapeutic Area Head, Cardiovascular and Metabolism at Janssen Research and Development discussed these two new medications and what their potential approval could mean to patients in the future.